Andy Hsu

579 total citations
10 papers, 401 citations indexed

About

Andy Hsu is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Andy Hsu has authored 10 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 4 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Andy Hsu's work include Multiple Myeloma Research and Treatments (6 papers), Immune Cell Function and Interaction (4 papers) and Protein Degradation and Inhibitors (2 papers). Andy Hsu is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Immune Cell Function and Interaction (4 papers) and Protein Degradation and Inhibitors (2 papers). Andy Hsu collaborates with scholars based in Australia, United States and United Kingdom. Andy Hsu's co-authors include Ross D. Hannan, Katherine M. Hannan, Amee J. George, Megan V. Astle, Rachel Lee, Ygal Haupt, Richard B. Pearson, Paul J. Neeson, David Ritchie and H. Miles Prince and has published in prestigious journals such as Blood, Oncogene and Japanese Journal of Applied Physics.

In The Last Decade

Andy Hsu

10 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andy Hsu Australia 6 200 113 106 104 75 10 401
H. Eugene Liu Taiwan 10 260 1.3× 124 1.1× 70 0.7× 48 0.5× 32 0.4× 16 436
Maxim Kebenko Germany 12 243 1.2× 265 2.3× 135 1.3× 165 1.6× 41 0.5× 30 609
Takuma Ishizaki Japan 11 193 1.0× 61 0.5× 113 1.1× 88 0.8× 20 0.3× 45 414
Charles O. Brown United States 10 149 0.7× 112 1.0× 29 0.3× 106 1.0× 44 0.6× 13 375
Gina M. Ney United States 12 273 1.4× 82 0.7× 58 0.5× 102 1.0× 18 0.2× 19 438
Laurie Lenox United States 7 139 0.7× 46 0.4× 66 0.6× 91 0.9× 137 1.8× 8 324
Daniela Bossi Italy 12 484 2.4× 182 1.6× 172 1.6× 48 0.5× 28 0.4× 18 658
Ashley M. Wellendorf United States 11 197 1.0× 54 0.5× 122 1.2× 137 1.3× 28 0.4× 22 401
Iris Appelmann Germany 11 236 1.2× 70 0.6× 108 1.0× 55 0.5× 15 0.2× 22 438

Countries citing papers authored by Andy Hsu

Since Specialization
Citations

This map shows the geographic impact of Andy Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy Hsu more than expected).

Fields of papers citing papers by Andy Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andy Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy Hsu. The network helps show where Andy Hsu may publish in the future.

Co-authorship network of co-authors of Andy Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Andy Hsu. A scholar is included among the top collaborators of Andy Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andy Hsu. Andy Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Thakkar, Hemanshoo, Andy Hsu, Dorothy Kufeji, et al.. (2016). Functional outcomes in Hirschsprung disease: A single institution's 12-year experience. Journal of Pediatric Surgery. 52(2). 277–280. 27 indexed citations
2.
Neeson, Paul J., Andy Hsu, Heloise M. Halse, et al.. (2015). Induction of potent NK cell-dependent anti-myeloma cytotoxic T cells in response to combined mapatumumab and bortezomib. OncoImmunology. 4(9). e1038011–e1038011. 5 indexed citations
4.
Hsu, Andy, Hang Quach, Simon J. Harrison, et al.. (2013). CD57+ NK CELLS ARE Increased In Patients With Multiple Myeloma and ARE Primed Effectors For ADCC, But NOT Natural Cytotoxicty. Blood. 122(21). 1904–1904. 3 indexed citations
5.
Hsu, Andy, David Ritchie, & Paul J. Neeson. (2012). Are the immuno-stimulatory properties of Lenalidomide extinguished by co-administration of Dexamethasone?. OncoImmunology. 1(3). 372–374. 10 indexed citations
6.
Astle, Megan V., Katherine M. Hannan, Rachel Lee, et al.. (2011). AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy. Oncogene. 31(15). 1949–1962. 215 indexed citations
8.
Hsu, Andy, Hang Quach, Tsin Yee Tai, et al.. (2011). Response: dexamethasone dose alters expression of NK activating receptors in vivo. Blood. 118(24). 6466–6468. 2 indexed citations
9.
Hsu, Andy, Hang Quach, Tsin Yee Tai, et al.. (2010). The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy. Blood. 117(5). 1605–1613. 125 indexed citations
10.
Liu, Yuchen, et al.. (2007). Environmental Cell Thinning of Advanced Liquid Crystal Displays. Japanese Journal of Applied Physics. 46(10R). 6688–6688. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026